Please assess the completion status of the following clinical trial:

Trial Title: Application of n-3 Fatty to Patient of Jaundice

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* the diagnosis of obstructive jaundice must be clear (serum toal bilirubin \>51.3umol/L \& Imaging evidence), and the obstruction is located in the extrahepatic bile duct;~* Duration of Jaundice is less than 2 weeks;~* Nutritional support is needed~* Nutritional support was administrated during the perioperative period;~* Drainage treatment is effective.~Exclusion Criteria:~* Contraindication for surgical procedure, including Child-Pugh Classification C, severe hemorrhagic disorders, gastrointestinal hemorrhage, acute infectious disease, active phase of chronic hepatitis B \& C, severe circulatory disease, renal failure pre -operation, and other unknown cause;~* Abandon treatment;~* Length of stay in hospital \<5 day;~* Nutrition support \<5 day;~* Conservative treatment;~* Incomplete data;~* Allergic reactions against PN.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- trail cohort (Type: None): n-3 FAs
- control cohort (Type: None): Structolipid

Based on this trial design, predict the completion outcome and termination type (if applicable).